Qube Research & Technologies (QRT)’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.3M Buy
3,188,657
+508,970
+19% +$3.54M 0.02% 876
2025
Q4
$18.9M Sell
2,679,687
-202,731
-7% -$1.22M 0.02% 948
2025
Q3
$15.9M Buy
2,882,418
+427,391
+17% +$2.09M 0.02% 1023
2025
Q2
$12.7M Buy
2,455,027
+1,166,045
+90% +$6.99M 0.01% 1149
2025
Q1
$8.58M Buy
1,288,982
+1,203,797
+1,413% +$9.15M 0.01% 1227
2024
Q4
$628K Buy
+85,185
New +$611K ﹤0.01% 2372
2022
Q2
Sell
-62,737
Closed -$634K 2861
2022
Q1
$634K Buy
+62,737
New +$551K 0.01% 1409
2021
Q3
Sell
-10,864
Closed -$303K 2526
2021
Q2
$303K Buy
+10,864
New +$287K ﹤0.01% 1575

Other funds holding LFST

Qube Research & Technologies (QRT)'s LFST Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Lifestance Health (LFST) stake by 19% in Q1 2026, buying an estimated $3.54M and bringing the position to 3,188,657 shares worth $20.3M. The position accounts for 0.02% of the portfolio, ranked #876.

Qube Research & Technologies (QRT) first reported a position in LFST in Q2 2021 and has held it in 8 quarters since. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Qube Research & Technologies (QRT) held 3,188,657 shares of Lifestance Health worth $20.3M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 508,970 Lifestance Health shares in Q1 2026, an estimated $3.54M.
  • Lifestance Health made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #876 holding.
  • Qube Research & Technologies (QRT) first reported a position in Lifestance Health in Q2 2021 and has held it in 8 quarters since.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.